Raj Chovatiya, MD, PhD, MSCI recently shared his thoughts on what he is looking forward to discussing with FIDE’s panel of experts at EADV 2024. Join FIDE for exclusive, expert-led discussion and analysis of the most impactful abstracts presented at EADV 2024 and understand how their clinical implications may shape future patient management. Reach out to us via LinkedIn or via FIDE.net/contact for more information. #dermatology #Immunology Expert Partnership
FIDE - Dermatology in Depth
Pharmaceutical Manufacturing
Access independent, unbiased expert insights from the FIDE faculty
About us
FIDE delivers dermatology consulting services and educational programs to the biotechnology, medical device, and pharmaceutical industries, as well as to the wider healthcare industry. We provide our clients with direct and unbiased views on clinical data and offer a full suite of services, including the FIDE Conference Analysis Program (CAP), strategic consulting, competitor analysis, market insight reports, and pipeline and portfolio strategy. Our expertise spans the pathophysiology, clinical presentation, and treatment of chronic dermatology indications, including psoriasis, psoriatic arthritis, atopic dermatitis, hidradenitis suppurativa, alopecia areata, and vitiligo. Our expert-led approach differs from conventional consultancy. We’re a network of more than 25 leading KOLs—including Dr. Bruce Strober, Dr. Ken Gordon and Dr. Richard Langley, that combines the latest therapy area intelligence with strategic consulting to improve healthcare outcomes and optimize business goals. The FIDE program is one several Expert Partnership programs. Visit our website below to view the full FIDE faculty as well as our various programs.
- Website
-
https://expertpartnership.com
External link for FIDE - Dermatology in Depth
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11-50 employees
- Headquarters
- London
- Type
- Partnership
- Founded
- 2010
- Specialties
- dermatology, education, insights, vitiligo, alopecia areata, healthcare, hidradenitis superativa, psoriasis, atopic dermatitis, chronic spontaneous urticaria, prurigo nodularis, biotech, and pharma
Locations
-
Primary
Get directions
London, GB
Employees at FIDE - Dermatology in Depth
Updates
-
Join FIDE in person at EADV 2024 to hear the independent insights of leading experts into new data presented at the congress. For more information, please contact [email protected]
-
Alan Irvine MD DSc recently shared his thoughts on what he is looking forward to discussing with FIDE’s panel of experts at EADV 2024. Join FIDE for exclusive, expert-led discussion and analysis of the most impactful abstracts presented at EADV 2024 and understand how their clinical implications may shape future patient management. Reach out to us via LinkedIn or via FIDE.net/contact for more information. #dermatology #immunology Expert Partnership
-
Bruce Strober recently shared his thoughts on what he is looking forward to discussing with FIDE’s panel of experts at EADV 2024. Join FIDE for exclusive, expert-led discussion and analysis of the most impactful abstracts presented at EADV 2024 and understand how their clinical implications may shape future patient management. Reach out to us via LinkedIn or via FIDE.net/contact for more information. #dermatology #immunology Expert Partnership
-
For more information on how to join FIDE's conference analysis programs, contact [email protected]
-
Outputs from FIDE’s first Early-stage Development Forum are NOW AVAILABLE. Our experts recently delivered their insights into the latest Phase 1 and 2 data for novel pipeline therapies, helping industry subscribers: •Inform early-phase clinical and strategic decision making •Identify differentiation opportunities versus established therapies •Optimize the development of novel therapeutics Check out what was covered during the event in the summary below, and contact [email protected] for access to the discussion and clinical insights slide deck
-
FIDE’s conference analysis programs provide subscribers with unprecedented independent insight direct from a network of leading dermatologists into the latest data presented at AAD and EADV. Panel discussion videos and expert insight slides from all our AAD 2024 programs are NOW AVAILABLE to subscribers #psoriasis #atopicdermatitis #hidradenitissuppurativa #vitiligo #alopeciaareata Missed FIDE at AAD 2024? Contact us via LinkedIn or [email protected] for access to the insights of an extended network of world-renowned experts into the most impactful data from the congress.
-
Join FIDE's leading faculty as they discuss the latest phase 1 and 2 data impacting the field of inflammatory skin diseases. For more information please contact us via LinkedIn or [email protected] Alan Irvine MD DSc Emma Guttman #Dermatology Expert Partnership
-
Professor Emma Guttman will join our panel of experts delivering independent insights into new data for emerging treatments in inflammatory skin diseases at FIDE’s first Early-stage Development Forum in May 2024. Scroll through the post below to see Professor Emma Guttman thoughts on how FIDE’s newest service can benefit your organization through discussion and contextualization of data for the next generation of therapies with novel mechanisms of action. Contact [email protected] for more information.
-
Professor Alan Irvine MD DSc will join our panel of experts delivering independent insights into new data for emerging treatments in inflammatory skin diseases at FIDE’s first Early-stage Development Forum in May 2024. Scroll through the post below to see Professor Alan Irvine MD DSc thoughts on how FIDE’s newest service can benefit your organization through discussion and contextualization of data for the next generation of therapies with novel mechanisms of action. Contact [email protected] for more information.